Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 4:58 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | VANGUARD GROUP INC | 4,680,716 6.25% | 307,539 (+7.03%) | View |
| 2024-02-09 08:35 am Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | FMR LLC | 4,728,782 6.317% | 4,728,782 (New Position) | View |
| 2024-01-31 4:58 pm Purchase | 13D | ARCUS BIOSCIENCES INC RCUS | GILEAD SCIENCES INC. GILD | 31,532,781 35% | 5,945,828 (+23.24%) | View |
| 2024-01-24 07:33 am Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | STATE STREET CORP STT | 4,239,577 5.66% | 4,239,577 (New Position) | View |
| 2024-01-23 11:52 am Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 10,035,170 13.4% | 646,122 (+6.88%) | View |
| 2023-07-06 09:38 am Purchase | 13D | ARCUS BIOSCIENCES INC RCUS | GILEAD SCIENCES INC. GILD | 25,586,953 35% | 2,863,797 (+12.60%) | View |
| 2023-02-14 4:06 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | PFM Health Sciences LP | 2,703,287 3.7% | -1,229,946 (-31.27%) | View |
| 2023-02-14 11:58 am Sale | 13G | ARCUS BIOSCIENCES INC RCUS | BIOTECHNOLOGY VALUE FUND L P | 2,303,520 3.2% | -1,657,428 (-41.84%) | View |
| 2023-02-09 5:42 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | EcoR1 Capital LLC | 0 0% | -5,523,358 (Position Closed) | View |
| 2023-02-09 11:07 am Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | VANGUARD GROUP INC | 4,373,177 6.04% | 4,373,177 (New Position) | View |
| 2023-01-26 08:43 am Unchanged | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 9,389,048 13% | 0 (Unchanged) | View |
| 2023-01-20 09:43 am Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 9,389,048 13% | 1,421,371 (+17.84%) | View |
| 2022-10-17 4:01 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | PFM Health Sciences LP | 3,933,233 5.5% | 502,223 (+14.64%) | View |
| 2022-05-09 3:23 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 7,967,677 11.1% | 3,837,748 (+92.93%) | View |
| 2022-03-14 4:48 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | BIOTECHNOLOGY VALUE FUND L P | 3,960,948 5.6% | 1,208,726 (+43.92%) | View |
| 2022-02-14 4:02 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | EcoR1 Capital LLC | 5,523,358 7.9% | 951,311 (+20.81%) | View |
| 2022-02-14 12:38 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | PFM Health Sciences LP | 3,431,010 4.9% | 57,550 (+1.71%) | View |
| 2022-02-14 12:30 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | GV 2016 L.P. | 2,563,441 3.65% | -2,486,345 (-49.24%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 4,129,929 5.9% | 758,628 (+22.50%) | View |
| 2021-07-19 5:16 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | EcoR1 Capital LLC | 4,572,047 6.4% | 4,572,047 (New Position) | View |